Matthew C. Hill - Jan 5, 2023 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Role
Chief Financial Officer
Signature
/s/ Matthew C. Hill
Stock symbol
PDSB
Transactions as of
Jan 5, 2023
Transactions value $
$0
Form type
4
Date filed
1/6/2023, 03:59 PM
Previous filing
Dec 14, 2021
Next filing
Dec 6, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PDSB Employee Stock Option (Right to Buy) Award $0 +161K $0.00 161K Jan 5, 2023 Common Stock 161K $11.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option, representing a right to purchase a total of 161,200 shares of Common Stock, will become exercisable on January 5, 2024, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 5, 2027.